Showing 16,621 - 16,640 results of 27,241 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 50 ((teer decrease) OR (mean decrease)) ))', query time: 1.04s Refine Results
  1. 16621
  2. 16622

    miRNA expression is altered in NSCs from diabetic pregnancy. by Sukanya Shyamasundar (420641)

    Published 2013
    “…The nucleus is counterstained with DAPI (blue). Scale bar: 50 µm. (C) miRNA expression analysis revealed decreased expression of miRNAs mmu-miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-466d-3p in NSCs from diabetic pregnancy (open bars) when compared to the control (filled bars). …”
  3. 16623
  4. 16624
  5. 16625
  6. 16626
  7. 16627

    Insulin treatment does not alter expression of anti-inflammatory markers YM1 and CD206. by Fiona Brabazon (5687624)

    Published 2018
    “…<p>Quantitation of western blots for YM1 showed that LPS exposure significantly decreased expression, but insulin had no effect (n = 3/group, A). …”
  8. 16628

    image_1.PDF by Emma J. Foster (5049770)

    Published 2018
    “…Total anterior circulation stroke and a prestroke modified Rankin Scale score of 3–5 were associated with decreased risk of both events, with hypertension and cancer decreasing risk of falls only.…”
  9. 16629

    Effect of four successive days of games in muscle power, perceived stress and recovery in futsal players by Victor Hugo FREITAS (12807314)

    Published 2022
    “…The CMJ showed a likely decrease before the second (0/19/81%), third (20/03/77%) and fourth game (01/10/89%) compared to before the first game. …”
  10. 16630

    Image 1_Hyperglycemia causes differential change in macrophage population in the lacrimal gland, conjunctiva and cornea.tif by Saleh Alfuraih (20451863)

    Published 2024
    “…</p>Results<p>Our data demonstrates the diabetes-associated hyperglycemia caused a rapid onset and significant decrease in macrophage population in lacrimal gland, conjunctiva and cornea. …”
  11. 16631
  12. 16632

    <i>In vitro</i> and <i>in vivo</i> antitumor activity of PEITC and Trisenox in imatinib resistant cells. by Jérome Kluza (5649763)

    Published 2011
    “…Cumulative survival data were compiled from two separate experiments and presented by a Kaplan–Meier survival analysis. GFP+ DA1-3b/M2 bearing mice were treated with Trisenox (4 mg/kg ip 5days/week) or PEITC (50 mg/kg ip 5days/week). …”
  13. 16633

    Data from: Increased Soil Nitrogen Availability Suppresses Annual Soil Respiration in Mixed Temperate Forests Regardless of Acidification by David W. Frey (21072152)

    Published 2025
    “…Treatments were selected for their abilities to increase (NaNO<sub>3</sub>) or decrease ((NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, S) soil pH. …”
  14. 16634

    Exocytosis of ATP from astrocytes down-regulates the tonic inhibitory synaptic signaling. by Ulyana Lalo (506296)

    Published 2014
    “…<p>(A, B) Tonic GABA-mediated signaling was evaluated by upward shift in the whole-cell holding current (ΔI<sub>hold</sub>) caused by application of bicuculline (50 µM) to the layer 2/3 pyramidal neurons in brain slices of wild-type (A) and dn-SNARE (B) mice. …”
  15. 16635

    Inverse relationship between the presence of Bax and Rad51. by Loro L. Kujjo (354585)

    Published 2013
    “…Values for each sample were determined as mean ± SEM per oocyte (AKR/J n = 50; C57BL/6 n = 50), and comparison was made between the two strains using Student's t-test. …”
  16. 16636

    PAI-1 inhibition leads to the accumulation of VE-cadherin at the Golgi apparatus. by Anna E. Daniel (841267)

    Published 2016
    “…<p>(A) HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and stained for VE-cadherin (green) and GM130 (red) (scale bar 50 μm). …”
  17. 16637
  18. 16638
  19. 16639

    Acceleration of nephron maturation and reduction of cap mesenchyme at E18.5 in Bmp7 knockout kidneys. by Mayumi Tomita (450540)

    Published 2013
    “…Scale bars: 100 µm (<b>D, G, L</b>) or 50 µm (<b>E, F, H, J</b>).</p>…”
  20. 16640

    DHEA and DHEA8354 suppress the growth of mammary tumors by Anne Shilkaitis (15502)

    Published 2011
    “…Growth curves of mammary tumors in animals treated with dehydroepiandrosterone (DHEA) (b) or DHEA 8354 (c) (1,000 mg/kg in diet). In 50% of DHEA-treated tumors a net decrease in growth potential over control was observed, whereas with DHEA 8354 some animals showed a decrease in growth potential. …”